Takeda Pharmaceutical Co Ltd (4502.T) Company Profile | Reuters.com
Edition:
United States

Profile: Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,462JPY
9:01pm EDT
Change (% chg)

¥22 (+0.50%)
Prev Close
¥4,440
Open
¥4,500
Day's High
¥4,505
Day's Low
¥4,459
Volume
427,900
Avg. Vol
2,691,506
52-wk High
¥6,609
52-wk Low
¥4,098

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

Company Address

Takeda Pharmaceutical Co Ltd

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI   OSK   540-8645
P: +816.62042111
F: +816.62042880

Company Web Links